Intriguingly, Myc, a key effector downstream of an array of oncogenic pathways, including RAS/Erk and PI3/Akt /mTOR, also serves as a master driver of cell metabolism in diverse cancer types, particularly for nutrients glutamine and glucose [43,90,91,92]. This evidence concerns the gene MYC and cancer.